ATE356608T1 - Behandlung der multiplen sklerose durch einnahme von copolymer-1 - Google Patents
Behandlung der multiplen sklerose durch einnahme von copolymer-1Info
- Publication number
- ATE356608T1 ATE356608T1 AT98901745T AT98901745T ATE356608T1 AT E356608 T1 ATE356608 T1 AT E356608T1 AT 98901745 T AT98901745 T AT 98901745T AT 98901745 T AT98901745 T AT 98901745T AT E356608 T1 ATE356608 T1 AT E356608T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- multiple sclerosis
- copolymer
- taking
- taking copolymer
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 230000037406 food intake Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11998997A IL119989A0 (en) | 1997-01-10 | 1997-01-10 | Pharmaceutical compositions for oral treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE356608T1 true ATE356608T1 (de) | 2007-04-15 |
Family
ID=11069682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98901745T ATE356608T1 (de) | 1997-01-10 | 1998-01-12 | Behandlung der multiplen sklerose durch einnahme von copolymer-1 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0975351B1 (enExample) |
| JP (1) | JP4216342B2 (enExample) |
| KR (1) | KR20000070058A (enExample) |
| CN (1) | CN100528222C (enExample) |
| AT (1) | ATE356608T1 (enExample) |
| AU (1) | AU737287B2 (enExample) |
| BR (1) | BRPI9807076B8 (enExample) |
| CA (1) | CA2277365C (enExample) |
| CZ (1) | CZ297983B6 (enExample) |
| DE (1) | DE69837324T2 (enExample) |
| EA (1) | EA003128B1 (enExample) |
| HU (1) | HU226612B1 (enExample) |
| IL (2) | IL119989A0 (enExample) |
| NZ (1) | NZ336690A (enExample) |
| PL (1) | PL193300B1 (enExample) |
| SK (1) | SK284029B6 (enExample) |
| WO (1) | WO1998030227A1 (enExample) |
| ZA (1) | ZA98214B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2337688C (en) | 1998-07-23 | 2016-04-05 | Yeda Research And Development Co., Ltd. | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
| AU766498B2 (en) * | 1998-07-23 | 2003-10-16 | President And Fellows Of Harvard College, The | Synthetic peptides and methods of use for autoimmune disease therapies |
| ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
| US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| DE60041365D1 (de) * | 1999-06-04 | 2009-02-26 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von Riluzol zur Behandlung Multipler Sklerose |
| WO2000074676A1 (en) * | 1999-06-04 | 2000-12-14 | Vereniging Voor Christelijk Wetenschappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
| MXPA02008023A (es) * | 2000-02-18 | 2005-06-30 | Yeda Res & Dev | Formulaciones de copolimero 1 para dosificacion oral, nasal y pulmonar. |
| US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| CA2411536A1 (en) * | 2000-06-05 | 2001-12-13 | V. Wee Yong | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| DE60237170D1 (de) | 2001-12-04 | 2010-09-09 | Teva Pharma | Verfahren zur messung der wirkstärke von glatirameracetat |
| KR20040105740A (ko) | 2002-02-25 | 2004-12-16 | 엘란 파마슈티칼스, 인크. | 염증 치료제의 투여 방법 |
| SK50642005A3 (sk) * | 2003-01-24 | 2006-02-02 | Elan Pharmaceuticals, Inc. | Kompozícia na liečenie demyelizačných ochorení a paralýzy podávaním remyelizačných látok |
| WO2006029411A2 (en) | 2004-09-09 | 2006-03-16 | Yeda Research And Development Co. Ltd. | Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
| UA103699C2 (ru) | 2009-08-20 | 2013-11-11 | Еда Рисёрч Энд Девелопмент Ко., Лтд. | Терапия глатирамера ацетатом с низкой частотой |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US8759302B2 (en) | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| EA025780B1 (ru) | 2010-10-11 | 2017-01-30 | Тева Фармасьютикал Индастриз Лтд. | Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат |
| CA2851510A1 (en) | 2011-10-10 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate |
| TW201420111A (zh) | 2012-10-10 | 2014-06-01 | Teva Pharma | 對格拉默醋酸鹽（ｇｌａｔｉｒａｍｅｒ ａｃｅｔａｔｅ）之臨床反應具預測性之生物標記 |
| UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
| CN105884866B (zh) * | 2015-01-26 | 2021-04-20 | 漳州未名博欣生物医药有限公司 | 格拉替雷的化学合成方法 |
| US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
| EP3603764B1 (en) * | 2015-04-28 | 2022-03-30 | Hybio Pharmaceutical Co., Ltd. | High performance liquid chromatography method for polypeptide mixtures |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| US12370233B2 (en) | 2016-08-31 | 2025-07-29 | Mapi Pharma Ltd. | Depot systems comprising glatiramer acetate |
| WO2018178973A1 (en) | 2017-03-26 | 2018-10-04 | Mapi Pharma Ltd. | Glatiramer depot systems for treating progressive forms of multiple sclerosis |
| CN110996983A (zh) | 2017-06-26 | 2020-04-10 | 巴斯德研究所 | 清除hiv储库并降低病毒载量的治疗 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
-
1997
- 1997-01-10 IL IL11998997A patent/IL119989A0/xx unknown
-
1998
- 1998-01-12 SK SK931-99A patent/SK284029B6/sk not_active IP Right Cessation
- 1998-01-12 EP EP98901745A patent/EP0975351B1/en not_active Expired - Lifetime
- 1998-01-12 EA EA199900621A patent/EA003128B1/ru not_active IP Right Cessation
- 1998-01-12 BR BRPI9807076A patent/BRPI9807076B8/pt not_active IP Right Cessation
- 1998-01-12 HU HU0001917A patent/HU226612B1/hu unknown
- 1998-01-12 PL PL334566A patent/PL193300B1/pl unknown
- 1998-01-12 WO PCT/US1998/000375 patent/WO1998030227A1/en not_active Ceased
- 1998-01-12 AU AU58195/98A patent/AU737287B2/en not_active Expired
- 1998-01-12 DE DE69837324T patent/DE69837324T2/de not_active Expired - Lifetime
- 1998-01-12 KR KR1019997006278A patent/KR20000070058A/ko not_active Ceased
- 1998-01-12 CA CA2277365A patent/CA2277365C/en not_active Expired - Lifetime
- 1998-01-12 NZ NZ336690A patent/NZ336690A/en not_active IP Right Cessation
- 1998-01-12 CZ CZ0243799A patent/CZ297983B6/cs not_active IP Right Cessation
- 1998-01-12 CN CNB988031221A patent/CN100528222C/zh not_active Expired - Lifetime
- 1998-01-12 ZA ZA9800214A patent/ZA98214B/xx unknown
- 1998-01-12 JP JP53110898A patent/JP4216342B2/ja not_active Expired - Lifetime
- 1998-01-12 AT AT98901745T patent/ATE356608T1/de not_active IP Right Cessation
-
1999
- 1999-07-06 IL IL130820A patent/IL130820A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0975351A1 (en) | 2000-02-02 |
| CN1249690A (zh) | 2000-04-05 |
| ZA98214B (en) | 1999-08-11 |
| HUP0001917A2 (hu) | 2000-10-28 |
| CN100528222C (zh) | 2009-08-19 |
| EA199900621A1 (ru) | 2000-02-28 |
| CA2277365A1 (en) | 1998-07-16 |
| JP2001511121A (ja) | 2001-08-07 |
| EP0975351B1 (en) | 2007-03-14 |
| IL119989A0 (en) | 1997-04-15 |
| HUP0001917A3 (en) | 2001-12-28 |
| JP4216342B2 (ja) | 2009-01-28 |
| DE69837324D1 (de) | 2007-04-26 |
| SK93199A3 (en) | 2000-11-07 |
| PL334566A1 (en) | 2000-03-13 |
| SK284029B6 (sk) | 2004-08-03 |
| NZ336690A (en) | 2001-05-25 |
| HU226612B1 (en) | 2009-04-28 |
| EA003128B1 (ru) | 2003-02-27 |
| CA2277365C (en) | 2011-04-12 |
| EP0975351A4 (en) | 2002-05-15 |
| IL130820A (en) | 2007-03-08 |
| AU5819598A (en) | 1998-08-03 |
| KR20000070058A (ko) | 2000-11-25 |
| BR9807076B1 (pt) | 2013-10-29 |
| PL193300B1 (pl) | 2007-01-31 |
| DE69837324T2 (de) | 2007-11-29 |
| WO1998030227A1 (en) | 1998-07-16 |
| AU737287B2 (en) | 2001-08-16 |
| BR9807076A (pt) | 2000-05-02 |
| HK1025737A1 (en) | 2000-11-24 |
| CZ297983B6 (cs) | 2007-05-16 |
| BRPI9807076B8 (pt) | 2021-05-25 |
| CZ243799A3 (cs) | 2000-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE356608T1 (de) | Behandlung der multiplen sklerose durch einnahme von copolymer-1 | |
| DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
| DE69326250D1 (de) | Neuropeptide y antagoniste | |
| ATE271128T1 (de) | Inhibitoren der il-6 aktivitaet | |
| UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
| DK1465626T3 (da) | Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf | |
| ATE423562T1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
| EA199900239A1 (ru) | Замещенные n-[аминоиминометил или аминометил) фенил] пропиламиды | |
| ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
| MX9706913A (es) | Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos. | |
| NO974147D0 (no) | Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease | |
| KR960006915A (ko) | 췌장염의 치료 조성물 | |
| ATE215817T1 (de) | Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis | |
| DE69820053D1 (de) | Stör-notokord zur verminderung der symptome / behandlung von arthritis | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| BG103632A (en) | Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment | |
| ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| DE60113664D1 (de) | Zusammensetzung zur behandlung von herzinsuffizienz | |
| ATE309803T1 (de) | Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung | |
| DK0977871T3 (da) | Neurotrypsin | |
| DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
| DE59303446D1 (de) | Neue bis-phenyl-hexene | |
| DK0539465T3 (da) | Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring | |
| ATE276272T1 (de) | Entzündungshemmende peptide | |
| RU93045696A (ru) | Ингибиторы протеазы вируса иммунодефицита человека, полезные для лечения спида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |